FR2555172B1 - 5,7-diene steroide, previtamine correspondante et isomere - Google Patents

5,7-diene steroide, previtamine correspondante et isomere

Info

Publication number
FR2555172B1
FR2555172B1 FR8415789A FR8415789A FR2555172B1 FR 2555172 B1 FR2555172 B1 FR 2555172B1 FR 8415789 A FR8415789 A FR 8415789A FR 8415789 A FR8415789 A FR 8415789A FR 2555172 B1 FR2555172 B1 FR 2555172B1
Authority
FR
France
Prior art keywords
steroide
isomer
diene
previtamin
corresponding previtamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8415789A
Other languages
English (en)
Other versions
FR2555172A1 (fr
Inventor
Hector F Deluca
Heinrich K Schnoes
Jacek W Morzycki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of FR2555172A1 publication Critical patent/FR2555172A1/fr
Application granted granted Critical
Publication of FR2555172B1 publication Critical patent/FR2555172B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
FR8415789A 1982-09-20 1984-10-15 5,7-diene steroide, previtamine correspondante et isomere Expired FR2555172B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/420,191 US4448721A (en) 1982-09-20 1982-09-20 Hydroxyvitamin D2 compounds and process for preparing same

Publications (2)

Publication Number Publication Date
FR2555172A1 FR2555172A1 (fr) 1985-05-24
FR2555172B1 true FR2555172B1 (fr) 1987-08-07

Family

ID=23665448

Family Applications (3)

Application Number Title Priority Date Filing Date
FR838314942A Expired FR2540869B1 (fr) 1982-09-20 1983-09-20 Procede pour la preparation de derives hydroxyles de la vitamine d2 et produits intermediaires utilises dans ce procede
FR8415789A Expired FR2555172B1 (fr) 1982-09-20 1984-10-15 5,7-diene steroide, previtamine correspondante et isomere
FR848415790A Expired FR2555173B1 (fr) 1982-09-20 1984-10-15 25-oh previtamine d2 et 5,7-diene 25 hydroxyle correspondant

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR838314942A Expired FR2540869B1 (fr) 1982-09-20 1983-09-20 Procede pour la preparation de derives hydroxyles de la vitamine d2 et produits intermediaires utilises dans ce procede

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR848415790A Expired FR2555173B1 (fr) 1982-09-20 1984-10-15 25-oh previtamine d2 et 5,7-diene 25 hydroxyle correspondant

Country Status (11)

Country Link
US (1) US4448721A (fr)
EP (1) EP0119251A1 (fr)
JP (6) JPS59501746A (fr)
CA (1) CA1283422C (fr)
CH (1) CH671222A5 (fr)
DE (2) DE3348322C2 (fr)
FR (3) FR2540869B1 (fr)
GB (2) GB2127023B (fr)
IE (1) IE56174B1 (fr)
IL (1) IL69763A (fr)
WO (1) WO1984001155A1 (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036061A (en) * 1983-05-09 1991-07-30 Deluca Hector F Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US5120722A (en) * 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
DE3590488T (de) * 1984-10-04 1986-10-09 Wisconsin Alumni Research Foundation, Madison, Wis. Vitamin D-Derivate und Verfahren zu deren Herstellung
US4857518A (en) * 1984-10-04 1989-08-15 Wisconsin Alumni Research Foundation Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same
US5225579A (en) * 1988-03-16 1993-07-06 Hoxan Corporation Method of manufacturing vitamin D2, Vitamin D3, activated type vitamin D2, activated type vitamin D3, and their derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
IN171449B (fr) * 1990-02-14 1992-10-17 Wisconsin Alumni Res Found
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
ATE240736T1 (de) * 1991-01-08 2003-06-15 Bone Care Int Inc Verfahren zur herstellung von 1-alpha-24- dihydroxy-vitamin d2
CA2129120A1 (fr) * 1992-01-29 1993-08-05 Joyce C. Knutson 1.alpha.-hydroxy-24-epi-vitamine d4
TW267161B (fr) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
JP4514452B2 (ja) * 2001-10-01 2010-07-28 ユニバーシティ オブ バージニア パテント ファウンデーション Ａ２ａアゴニスト活性を有する２−プロピルアデノシン・アナログおよびその組成物
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US7947682B2 (en) * 2004-12-29 2011-05-24 University Of Southern California Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents
HUE029572T2 (en) 2006-02-03 2017-03-28 Opko Renal Llc Treatment of Vitamin D Insufficiency and Deficiency with 25-Hydroxy-D2 and 25-Hydroxy-D3
WO2007120972A2 (fr) * 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Procede permettant de traiter l'anemie a hematies falciformes
US8188063B2 (en) * 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8329677B2 (en) 2006-06-21 2012-12-11 Cytochroma, Inc. Method of treating and preventing secondary hyperparathyroidism
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
EP3542792B1 (fr) 2007-04-25 2023-06-28 EirGen Pharma Ltd. Libération contrôlée de 25-hydroxyvitamine d
US8058259B2 (en) * 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
KR101852042B1 (ko) 2008-04-02 2018-04-25 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
CN102131773B (zh) * 2008-07-22 2014-09-24 Azad药物成分股份公司 生产帕立骨化醇的方法
KR20170096238A (ko) * 2009-01-27 2017-08-23 베르그 엘엘씨 화학요법과 연관된 부작용을 경감시키기 위한 비타민 ｄ３ 및 이의 유사물
JP5978130B2 (ja) 2009-08-14 2016-08-24 バーグ エルエルシー 脱毛症を治療するためのビタミンｄ３およびその類似体
LT2552484T (lt) 2010-03-29 2020-04-27 Opko Ireland Global Holdings, Ltd. Būdai ir kompozicijos, skirti paratiroidų lygiams sumažinti
CA2698160C (fr) * 2010-03-30 2017-07-25 Alphora Research Inc. Doxercalciferol stabilise et procede pour le produire
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
EP3003497B1 (fr) 2013-05-29 2024-02-14 BPGbio, Inc. Prévention ou atténuation de l'alopécie induite par la chimiothérapie au moyen de vitamine d
CN114681468A (zh) 2014-08-07 2022-07-01 欧普科爱尔兰环球控股有限公司 利用25-羟基维生素d的辅助疗法
TW202214257A (zh) 2016-03-28 2022-04-16 愛爾蘭商歐科愛爾蘭全球控股股份有限公司 維生素d治療之方法
CN115947678B (zh) * 2023-03-10 2024-01-16 成都诺森医学检验有限公司 稳定同位素2h（d）标记25-羟基维生素d2的合成方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL150682B (nl) * 1968-07-01 1976-09-15 Wisconsin Alumni Res Found Werkwijze ter bereiding van een farmacologisch werkzaam preparaat, dat een vitamine d-derivaat bevat, alsmede gevormde voedingsmiddelen.
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4105660A (en) * 1977-06-29 1978-08-08 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5,7-dien-25-one
US4145346A (en) * 1977-10-03 1979-03-20 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5-ene-25-one and intermediates thereof
US4229358A (en) * 1978-07-26 1980-10-21 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4265822A (en) * 1979-09-10 1981-05-05 Wisconsin Alumni Research Foundation Process for preparing 1-hydroxylated vitamin D compounds from 5,6-trans-vitamin D compounds
DE3048698A1 (de) * 1980-12-23 1982-07-15 Wisconsin Alumni Research Foundation, 53707 Madison, Wis. Verfahren zur herstellung einer 1(alpha)-hydroxylierten vitamin-d-verbindung, ausgehend von einer 5,6-trans-vitamin-d-verbindung

Also Published As

Publication number Publication date
DE3390212C2 (fr) 1991-10-31
JPS59501746A (ja) 1984-10-18
CA1283422C (fr) 1991-04-23
EP0119251A1 (fr) 1984-09-26
JPH0443916B2 (fr) 1992-07-20
DE3348322C2 (fr) 1991-07-25
JPH0518839B2 (fr) 1993-03-15
US4448721A (en) 1984-05-15
JPH0518840B2 (fr) 1993-03-15
JPH02209862A (ja) 1990-08-21
JPH02209863A (ja) 1990-08-21
FR2555173B1 (fr) 1989-04-07
FR2540869A1 (fr) 1984-08-17
CH671222A5 (fr) 1989-08-15
GB2142922B (en) 1986-08-28
IL69763A (en) 1987-01-30
GB8417477D0 (en) 1984-08-15
DE3390212T1 (de) 1984-11-29
IE832203L (en) 1984-03-20
JPH02209887A (ja) 1990-08-21
JPH02209888A (ja) 1990-08-21
GB2142922A (en) 1985-01-30
JPH02209864A (ja) 1990-08-21
WO1984001155A1 (fr) 1984-03-29
GB8325131D0 (en) 1983-10-19
GB2127023A (en) 1984-04-04
FR2540869B1 (fr) 1988-04-15
JPH0435458B2 (fr) 1992-06-11
GB2127023B (en) 1987-07-08
IL69763A0 (en) 1983-12-30
IE56174B1 (en) 1991-05-08
FR2555172A1 (fr) 1985-05-24
JPH0434540B2 (fr) 1992-06-08
JPH0610187B2 (ja) 1994-02-09
FR2555173A1 (fr) 1985-05-24

Similar Documents

Publication Publication Date Title
FR2555172B1 (fr) 5,7-diene steroide, previtamine correspondante et isomere
FI833125A (fi) Foerfarande foer att framstaella saendningsklara paket ur tryckalster som faerdigstaells i fjaellarformation
FI832171L (fi) Regulator foer genomstoemningsmaengden
DK52483D0 (da) Immunoassay
NO843406L (no) Steroider
FI823475A0 (fi) Saett att utvinna metaller ur flytande slagg
DK49983D0 (da) Oximethere
FI832266A0 (fi) Lokala kortikosteroidpreparat
DE3479763D1 (de) Corona discharge device
FI830185A0 (fi) Tillvaratagande av metaller ur skaerstenar
AT375505B (de) Tuner
FI833584A (fi) Avskiljning av arsenik ur en kopparelektrolyt
DK136783D0 (da) Spaendingsregulator
FI824454A0 (fi) Foerfarande foer utvinning av laxativa foereningar ur sennadrog
FI832900A0 (fi) Isolering av mikrobiella polysackarider ur deras aminaddukter
DE3486450T2 (de) 17-Alpha-Ethynyl Steroide
FI833799A (fi) Urvattning ur naturfuktig raotorv
FI822982A0 (fi) Foerfarande foer avlaegsnande av arsenik ur en svavelsyrahaltig loesning
DK89483A (da) Spaendingsdobler
DE3363289D1 (de) Sulfon amides
FI834194A0 (fi) Preparat foer munvaord
FI834384A0 (fi) Framstaellningsfoerfarande foer 4(5)-acetyl-2-metylimidazol
BR6200213U (pt) Central eletrica
FI821880A0 (fi) Reglermekanism foer vilstol
KR830003836U (ko) 노트 체결구